Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors
| Autor: | Sertaç İşlekel, Nilgün Yünten, Taskin Yurtseven, Taner Akalin, Cem Calli, Omer Kitis |
|---|---|
| Rok vydání: | 2006 |
| Předmět: |
Adult
Male Adolescent Lymphoma Contrast Media Astrocytoma Metastasis White matter Central nervous system disease medicine Humans Radiology Nuclear Medicine and imaging Child Aged Blood Volume medicine.diagnostic_test Brain Neoplasms business.industry Magnetic resonance imaging General Medicine Middle Aged Image Enhancement medicine.disease Diffusion Magnetic Resonance Imaging medicine.anatomical_structure Cerebrovascular Circulation Female Glioblastoma business Nuclear medicine Perfusion Magnetic Resonance Angiography Anaplastic astrocytoma |
| Zdroj: | European Journal of Radiology. 58:394-403 |
| ISSN: | 0720-048X |
| DOI: | 10.1016/j.ejrad.2005.12.032 |
| Popis: | Common contrast-enhancing malignant tumors of the brain are glioblastoma multiforme (GBMs), anaplastic astrocytomas (AAs), metastases, and lymphomas, all of which have sometimes similar conventional MRI findings. Our aim was to evaluate the role of perfusion MR imaging (PWI) and diffusion-weighted imaging (DWI) in the differentiation of these contrast-enhancing malignant cerebral tumors.Forty-eight patients with contrast-enhancing and histologically proven brain tumors, 14 AAs, 17 GBMs, nine metastases, and eight lymphomas, were included in the study. All patients have undergone routine MR examination where DWI and PWI were performed in the same session. DWI was performed with b values of 0, 500, and 1000 mm(2)/s. Minimum ADC values (ADC(min)) of each tumor was later calculated from ADC map images. PWI was applied using dynamic susceptibility contrast technique and maximum relative cerebral blood volume (rCBV(max)) was calculated from each tumor, given in ratio with contralateral normal white matter. Comparisons of ADC(min) and rCBV(max) values with the histological types of the enhancing tumors were made with a one-way analysis of variance and Bonferroni test. A P value less than 0.05 indicated a statistically significant difference.The ADC(min) values (mean+/-S.D.) in GBMs, AAs, lymphomas, and metastases were 0.79+/-0.21 (x10(-3)mm(2)/s), 0.75+/-0.21 (x10(-3)mm(2)/s), 0.51+/-0.09 (x10(-3)mm(2)/s), and 0.68+/-0.11 (x10(-3)mm(2)/s), respectively. The difference in ADC(min) values were statistically significant between lymphomas and GBMs (P0.05). It was also statistically significant between lymphomas and AAs (P0.03). However, there were no differences between lymphomas and metastasis, and between GBMs, AAs, and metastasis. The rCBV(max) ratio (mean+/-S.D.) in GBMs were 6.33+/-2.03, whereas it was 3.66+/-1.79 in AAs, 2.33+/-0.68 in lymphomas, and 4.45+/-1.87 in metastases. These values were statistically different between GBMs and AAs (P0.001), GBMs and lymphoma (P0.0001). Although there seemed to be difference between GBMs and metastases, it was not statistically significant (P0.083).Combination of DWI and PWI, with ADC(min) and rCBV(max) calculations, may aid routine MR imaging in the differentiation of common cerebral contrast-enhancing malignant tumors. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect